ATC Group: L01CA01 Vinblastine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01CA01 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01C Plant alkaloids and other natural products
4 L01CA Vinca alkaloids and analogues
5 L01CA01 Vinblastine

Active ingredients in L01CA01

Active Ingredient Description
Vinblastine

Vinblastine appears to bind to or crystallise critical microtubular proteins of the mitotic spindle, thus preventing their proper polymerisation and causing metaphase arrest. In high concentrations, vinblastine also exerts complex effects on nucleic acid and protein synthesis.

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Finland (FI)

France (FR)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.